Imperial College London

DrRichardNicholas

Faculty of MedicineDepartment of Brain Sciences

Professor of Practice (Neurology)
 
 
 
//

Contact

 

r.nicholas

 
 
//

Location

 

12L12CLab BlockCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Vermersch:2018,
author = {Vermersch, P and Comi, G and Siva, A and Oreja-Guevara, C and Wiendl, H and Van, Wijmeersch B and Eralinna, J-P and Nicholas, R and Buffels, R and Bernasconi, C and Kuhelj, R},
pages = {190--190},
publisher = {WILEY},
title = {Baseline characteristics of the CASTING Study population: a Phase IIIB Trial evaluating Ocrelizumab in patients with relapsing-remitting Multiple Sclerosis and suboptimal response to disease-modifying therapies},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435272001169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Vermersch,P
AU - Comi,G
AU - Siva,A
AU - Oreja-Guevara,C
AU - Wiendl,H
AU - Van,Wijmeersch B
AU - Eralinna,J-P
AU - Nicholas,R
AU - Buffels,R
AU - Bernasconi,C
AU - Kuhelj,R
EP - 190
PB - WILEY
PY - 2018///
SN - 1351-5101
SP - 190
TI - Baseline characteristics of the CASTING Study population: a Phase IIIB Trial evaluating Ocrelizumab in patients with relapsing-remitting Multiple Sclerosis and suboptimal response to disease-modifying therapies
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435272001169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -